Additionally, in CTCs from breast cancer patients, upregulation of glucose-6-phosphate dehydrogenase (G6PD), a key enzyme in the pentose phosphate pathway (PPP), has been correlated with tumor metastasis and progression40. Here, G6PD is linked to neoplasm.